A proposal to rename small low-risk papillary thyroid cancers (sPTCs) to discourage overtreatment has met with a mixed reception from the public. Experts have suggested changing terminology to better communicate the indolent nature of sPTCs and improve uptake of active surveillance rather the current preferred pathway of surgery. In a recent BMJ paper they said ...
Unease over proposal to remove ‘cancer’ label from low risk thyroid cancers
By Michael Woodhead
2 Dec 2020